Outset Medical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Outset Medical, Inc. (OM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-02-28
- Outset Medical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- Outset Medical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Outset Medical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.00 shares, a 100.00% decline from fiscal 2021.
- Outset Medical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 634.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2024-12-31 | 0.00 shares 10-K · filed 2025-02-28 |
| 2023-12-31 | 0.00 shares 10-K · filed 2024-02-21 |
| 2022-12-31 | 1.00 shares 10-K · filed 2023-02-13 |
| 2021-12-31 | 634.00K shares 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |